Saccharomyces cerevisiae‐ and Candida albicans‐Derived Mannan Induced Production of Tumor Necrosis Factor Alpha by Human Monocytes in a CD14‐ and Toll‐Like Receptor 4‐Dependent Manner
暂无分享,去创建一个
E. Nemoto | H. Shimauchi | K. Shibata | K. Miyake | H. Tamura | N. Ohno | T. Mikami | H. Tada | S. Sugawara | S. Akashi | H. Takada | Toshihiko Watanabe | Tatsuji Matsumoto
[1] T. Ogawa,et al. Bacterial Fimbriae and Their Peptides Activate Human Gingival Epithelial Cells through Toll-Like Receptor 2 , 2001, Infection and Immunity.
[2] S. Akira,et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.
[3] K. Miyake,et al. Micrococcus luteus Teichuronic Acids Activate Human and Murine Monocytic Cells in a CD14- and Toll-Like Receptor 4-Dependent Manner , 2001, Infection and Immunity.
[4] A. Aasen,et al. Involvement of CD14 and Toll-Like Receptors in Activation of Human Monocytes by Aspergillus fumigatus Hyphae , 2001, Infection and Immunity.
[5] S. Ghosh,et al. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. , 2001, The Journal of clinical investigation.
[6] A. Aderem,et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] P. Chiani,et al. Differential chemokine response of human monocytes to yeast and hyphal forms of Candida albicans and its relation to the β‐1,6 glucan of the fungal cell wall , 2000, Journal of leukocyte biology.
[8] L. Ryan,et al. The cytokine stimulating activity of (1-->3)-beta-D-glucans is dependent on the triple helix conformation. , 2000, Carbohydrate research.
[9] P. Godowski,et al. Toll-Like Receptor 4, But Not Toll-Like Receptor 2, Is a Signaling Receptor for Escherichia and Salmonella Lipopolysaccharides1 , 2000, The Journal of Immunology.
[10] F. Mustafa,et al. Candida albicans and Saccharomyces cerevisiae cell wall mannans produce fever in rats: role of nitric oxide and cytokines. , 2000, Life sciences.
[11] Y. Adachi,et al. Measurement of blood clearance time by Limulus G test of Candida-water soluble polysaccharide fraction, CAWS, in mice. , 2000, FEMS immunology and medical microbiology.
[12] S. Vogel,et al. Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.
[13] P. Tobias,et al. LPS and LAM activation of the U373 astrocytoma cell line: Differential requirement for CD14 , 2000, Journal of endotoxin research.
[14] Y. Adachi,et al. Immunopharmacological and immunotoxicological activities of a water-soluble (1-->3)-beta-D-glucan, CSBG from Candida spp. , 2000, International journal of immunopharmacology.
[15] K. Takeda,et al. Cutting Edge: Cell Surface Expression and Lipopolysaccharide Signaling Via the Toll-Like Receptor 4-MD-2 Complex on Mouse Peritoneal Macrophages1 , 2000, The Journal of Immunology.
[16] D. Golenbock,et al. Human Toll-Like Receptor 2 Mediates Monocyte Activation by Listeria monocytogenes, But Not by Group B Streptococci or Lipopolysaccharide1 , 2000, The Journal of Immunology.
[17] S. Akira,et al. Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway1 , 2000, The Journal of Immunology.
[18] D. Golenbock,et al. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. , 1999, Journal of immunology.
[19] A. Aderem,et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.
[20] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[21] M. Gershwin,et al. Mushrooms, tumors, and immunity. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[22] Y. Adachi,et al. Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp. , 1999, FEMS immunology and medical microbiology.
[23] Yoshinori Nagai,et al. MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.
[24] L. Larivière,et al. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. , 1999, Journal of immunology.
[25] V. Vetvicka,et al. Therapeutic intervention with complement and β-glucan in cancer , 1999 .
[26] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[27] Y. Adachi,et al. Solubilization of yeast cell-wall beta-(1-->3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. , 1999, Carbohydrate research.
[28] L. Larivière,et al. Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.
[29] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[30] M. Rothe,et al. Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide , 1998, The Journal of experimental medicine.
[31] A. Gurney,et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling , 1998, Nature.
[32] J. Berman,et al. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. , 1998, Science.
[33] G. Fink,et al. Nonfilamentous C. albicans Mutants Are Avirulent , 1997, Cell.
[34] C. Janeway,et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.
[35] J. Hudson,et al. Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum , 1996, Infection and immunity.
[36] T. Kirkland,et al. CD14 Is a Cell-activating Receptor for Bacterial Peptidoglycan* , 1996, The Journal of Biological Chemistry.
[37] K. Murphy,et al. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway , 1996, Infection and immunity.
[38] D. Wachsmann,et al. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-alpha release. , 1995, Journal of immunology.
[39] H. Flad,et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures , 1994, Infection and immunity.
[40] A. Tomasz,et al. CD14 is a pattern recognition receptor. , 1994, Immunity.
[41] R. Sawyer,et al. Secretion of TNF‐α by alveolar macrophages in response to Candida albicans mannan , 1994, Journal of leukocyte biology.
[42] M. Otterlei,et al. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction , 1993, Infection and immunity.
[43] T. Lee,et al. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. , 1993, The Journal of clinical investigation.
[44] M. Puliti,et al. Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans , 1992, Infection and immunity.
[45] R. Nelson,et al. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action , 1991, Clinical Microbiology Reviews.
[46] R. Ulevitch,et al. Structure and function of lipopolysaccharide binding protein. , 1990, Science.
[47] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.
[48] S. Goyert,et al. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. , 1988, Journal of immunology.
[49] R. Ulevitch,et al. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum , 1986, The Journal of experimental medicine.
[50] H. Tamura,et al. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[51] T. Mikami,et al. Lethal Effect of Neutral Mannan Fraction of Bakers' Yeast in Mice , 1984, Microbiology and immunology.
[52] T. Mikami,et al. Pyrogenicity of Yeast Mannans in Rabbits , 1984, Microbiology and immunology.
[53] W. Bessler,et al. Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. , 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[54] W. Bessler,et al. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein. , 1982, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[55] T. Mikami,et al. Action of alkaline sodium borohydride on fractions of d-mannans from bakers' yeast (Saccharomyces cerevisiae) , 1982 .
[56] M. Suzuki,et al. Growth-inhibitory activity of the D-mannan of Saccharomyces cerevisiae X2180-1A-5 mutant strain against mouse-implanted sarcoma 180 and Ehrlich-carcinoma solid tumor. , 1980, Carbohydrate research.
[57] T. Mikami,et al. Preparation of yeast mannan derivatives by stearoylation and phosphorylation. , 1976, Chemical & pharmaceutical bulletin.
[58] A. Wardlaw,et al. THE PROPERDIN SYSTEM AND IMMUNITY , 1956, The Journal of experimental medicine.
[59] Louis Pillemer,et al. THE PROPERDIN SYSTEM AND IMMUNITY III. THE ZYMOSAN ASSAY OF PROPERDIN , 1956 .